These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population. Nestor A; Calhoun AC; Dickson M; Kalik CA Ann Allergy Asthma Immunol; 1998 Oct; 81(4):327-30. PubMed ID: 9809496 [TBL] [Abstract][Full Text] [Related]
4. Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients. Navaratnam P; Friedman HS; Urdaneta E Value Health; 2011; 14(2):339-46. PubMed ID: 21402302 [TBL] [Abstract][Full Text] [Related]
5. Factors associated with the control of severe asthma. Hermosa JL; Sánchez CB; Rubio MC; Mínguez MM; Walther JL J Asthma; 2010 Mar; 47(2):124-30. PubMed ID: 20170317 [TBL] [Abstract][Full Text] [Related]
6. Association between availability of non-prescription beta 2 agonist inhalers and undertreatment of asthma. Gibson P; Henry D; Francis L; Cruickshank D; Dupen F; Higginbotham N; Henry R; Sutherland D BMJ; 1993 Jun; 306(6891):1514-8. PubMed ID: 8518681 [TBL] [Abstract][Full Text] [Related]
7. Over-prescription of short-acting β Smith C; Ambaram A; Mitha E; Abdullah I; Abdullah IA; Reddy J; Trokis J; Ramlachan P; Govind U; Lightfoot K; Moodley K; Smit R; Beekman MJHI Afr J Thorac Crit Care Med; 2022; 28(4):. PubMed ID: 36874189 [TBL] [Abstract][Full Text] [Related]
8. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208 [TBL] [Abstract][Full Text] [Related]
9. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma. Blanchette CM; Culler SD; Ershoff D; Gutierrez B Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003 [TBL] [Abstract][Full Text] [Related]
10. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study. Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228 [TBL] [Abstract][Full Text] [Related]
11. Impact of asthma control on sleep, attendance at work, normal activities, and disease burden. Wertz DA; Pollack M; Rodgers K; Bohn RL; Sacco P; Sullivan SD Ann Allergy Asthma Immunol; 2010 Aug; 105(2):118-23. PubMed ID: 20674821 [TBL] [Abstract][Full Text] [Related]
12. The Association Between Short-Acting β Price D; Jenkins C; Hancock K; Vella R; Heraud F; Le Cheng P; Murray R; Beekman M; Bosnic-Anticevich S; Botini F; Carter V; Catanzariti A; Doan J; Fletton K; Kichkin A; Le T; Le Lievre C; Lau CM; Novic D; Pakos J; Ranasinghe K; Roussos A; Samuel-King J; Sharma A; Stewart D; Willet B; Bateman E; Adv Ther; 2024 Mar; 41(3):1262-1283. PubMed ID: 38310584 [TBL] [Abstract][Full Text] [Related]
13. Patterns of asthma medication use: early asthma therapy initiation and asthma outcomes at age 8. Koster ES; Wijga AH; Zuidgeest MG; Belitser SV; Raaijmakers JA; Koppelman GH; Postma DS; Brunekreef B; de Jongste JC; Maitland-van der Zee AH Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):991-9. PubMed ID: 20712022 [TBL] [Abstract][Full Text] [Related]
14. Pharmacy-specific quality indicators for asthma therapy. Winterstein AG; Hartzema AG Res Social Adm Pharm; 2005 Sep; 1(3):430-45. PubMed ID: 17138488 [TBL] [Abstract][Full Text] [Related]
15. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [TBL] [Abstract][Full Text] [Related]
16. Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control. Armour CL; Lemay K; Saini B; Reddel HK; Bosnic-Anticevich SZ; Smith LD; Burton D; Song YJ; Alles MC; Stewart K; Emmerton L; Krass I J Asthma; 2011 Nov; 48(9):914-22. PubMed ID: 21942306 [TBL] [Abstract][Full Text] [Related]
17. Over-prescription of short-acting β Khattab A; Madkour A; Ambaram A; Smith C; Muhwa CJ; Mecha JO; Alsayed M; Beekman MJHI Curr Med Res Opin; 2022 Nov; 38(11):1983-1995. PubMed ID: 36031882 [TBL] [Abstract][Full Text] [Related]
18. Overprescription of short-acting β Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074 [TBL] [Abstract][Full Text] [Related]
19. The impact of alexithymia on asthma patient management and communication with health care providers: a pilot study. Chugg K; Barton C; Antic R; Crockett A J Asthma; 2009 Mar; 46(2):126-9. PubMed ID: 19253116 [TBL] [Abstract][Full Text] [Related]
20. Depressive symptoms, low adherence, and poor asthma outcomes in the elderly. Krauskopf KA; Sofianou A; Goel MS; Wolf MS; Wilson EA; Martynenko ME; Halm EA; Leventhal H; Feldman JM; Federman AD; Wisnivesky JP J Asthma; 2013 Apr; 50(3):260-6. PubMed ID: 23294120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]